NASDAQ:HSIC - Henry Schein Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$73.29 +0.41 (+0.56 %)
(As of 06/17/2018 04:00 PM ET)
Previous Close$73.29
Today's Range$72.08 - $73.41
52-Week Range$62.56 - $93.14
Volume1.67 million shs
Average Volume1.17 million shs
Market Capitalization$11.29 billion
P/E Ratio20.36
Dividend YieldN/A

About Henry Schein (NASDAQ:HSIC)

Henry Schein logoHenry Schein, Inc. provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides animal health products, such as branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. The company was founded in 1932 and is headquartered in Melville, New York.

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors


Debt-to-Equity Ratio0.34
Current Ratio1.44
Quick Ratio0.74


Trailing P/E Ratio20.36
Forward P/E Ratio17.88
P/E Growth1.74

Sales & Book Value

Annual Sales$12.46 billion
Price / Sales0.91
Cash Flow$4.8633 per share
Price / Cash15.07
Book Value$18.00 per share
Price / Book4.07


EPS (Most Recent Fiscal Year)$3.60
Net Income$406.29 million
Net Margins3.18%
Return on Equity19.68%
Return on Assets7.59%


Outstanding Shares154,020,000

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Henry Schein's stock split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its board has authorized a share repurchase plan on Tuesday, September 19th 2017, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 6.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) released its quarterly earnings results on Tuesday, May, 8th. The company reported $0.95 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.92 by $0.03. The business earned $3.22 billion during the quarter, compared to the consensus estimate of $3.18 billion. Henry Schein had a return on equity of 19.68% and a net margin of 3.18%. The business's revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.88 earnings per share. View Henry Schein's Earnings History.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein issued an update on its FY18 earnings guidance on Tuesday, May, 8th. The company provided earnings per share (EPS) guidance of $4.03-4.14 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.09.

What price target have analysts set for HSIC?

19 brokers have issued 12-month price objectives for Henry Schein's stock. Their forecasts range from $73.00 to $102.00. On average, they expect Henry Schein's stock price to reach $81.50 in the next twelve months. View Analyst Ratings for Henry Schein.

What are Wall Street analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:
  • 1. Barrington Research analysts commented, "We are currently modeling $4.08. It is important to note that management’s adjusted EPS guidance does not include any impact from the upcoming animal health spin-off and merger, which is expected to occur before year end. In addition, the guidance does not factor in any future M&A activity." (5/10/2018)
  • 2. According to Zacks Investment Research, "Henry Schein exited first-quarter 2018 on a strong note with earnings and revenues steering past the Zacks Consensus Estimate. All four operating segments recorded strong year-over-year growth. Henry Schein's strong share gains in the North American and overseas markets along with solid revenues raise optimism. Despite the better-than-expected revenue performance, we are disappointed with the year-over-year deterioration in Henry Schein's gross and operating margin due to higher costs and expenses. We currently await the completion of the company’s global Animal Health business' planned spin-off. This business contributes nearly 30% to the company’s topline. The spin off is expected to bring in major changes to Henry Schein’s overall operating results. On the flip side, pricing pressure and tough competition are major woes. Overall, in the past three months, Henry Schein has outperformed the broader industry." (5/10/2018)

Are investors shorting Henry Schein?

Henry Schein saw a increase in short interest in the month of May. As of May 31st, there was short interest totalling 20,773,220 shares, an increase of 12.3% from the May 15th total of 18,492,187 shares. Based on an average daily trading volume, of 1,381,966 shares, the days-to-cover ratio is currently 15.0 days. Currently, 13.7% of the shares of the stock are sold short.

Who are some of Henry Schein's key competitors?

Who are Henry Schein's key executives?

Henry Schein's management team includes the folowing people:
  • Mr. Stanley M. Bergman, Exec. Chairman & CEO (Age 68)
  • Mr. James P. Breslawski, Vice Chairman & Pres (Age 64)
  • Mr. Steven Paladino, Exec. VP, CFO & Exec. Director (Age 61)
  • Mr. Gerald A. Benjamin, Exec. VP, Chief Admin. Officer & Director (Age 65)
  • Mr. Robert Minowitz, Sr. VP of Global Dental Merchandising & Bus. Operations (Age 59)

Has Henry Schein been receiving favorable news coverage?

Press coverage about HSIC stock has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Henry Schein earned a media sentiment score of 0.20 on Accern's scale. They also gave press coverage about the company an impact score of 45.05 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.50%), Select Equity Group L.P. (4.20%), Alecta Pensionsforsakring Omsesidigt (3.57%), JPMorgan Chase & Co. (1.66%), Atlanta Capital Management Co. L L C (1.61%) and Swedbank (1.41%). Company insiders that own Henry Schein stock include Barry J Alperin, Donald J Kabat, Gerald A Benjamin, James A Harding, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Brons, Paul Rose, Philip A Laskawy and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

Which major investors are selling Henry Schein stock?

HSIC stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Green Valley Investors LLC, BlackRock Inc., Virginia Retirement Systems ET AL, Glen Harbor Capital Management LLC, Neuberger Berman Group LLC, Russell Investments Group Ltd. and Swedbank. Company insiders that have sold Henry Schein company stock in the last year include Barry J Alperin, Mark E Mlotek, Paul Brons and Paul Rose. View Insider Buying and Selling for Henry Schein.

Which major investors are buying Henry Schein stock?

HSIC stock was purchased by a variety of institutional investors in the last quarter, including Select Equity Group L.P., American Century Companies Inc., Kovitz Investment Group Partners LLC, Wells Fargo & Company MN, Alecta Pensionsforsakring Omsesidigt, New York State Common Retirement Fund, Polar Asset Management Partners Inc. and The Manufacturers Life Insurance Company . View Insider Buying and Selling for Henry Schein.

How do I buy shares of Henry Schein?

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $73.29.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $11.29 billion and generates $12.46 billion in revenue each year. The company earns $406.29 million in net income (profit) each year or $3.60 on an earnings per share basis. Henry Schein employs 22,000 workers across the globe.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]

MarketBeat Community Rating for Henry Schein (HSIC)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  198 (Vote Outperform)
Underperform Votes:  390 (Vote Underperform)
Total Votes:  588
MarketBeat's community ratings are surveys of what our community members think about Henry Schein and other stocks. Vote "Outperform" if you believe HSIC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSIC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.